The ACE program brings together basic scientists and clinicians from leading research institutions to evaluate the safety and efficacy of treatment strategies for autoimmune diseases. ACEs investigators also explore the immune mechanisms underlying the agents evaluated in these trials – research that commonly is not included in other clinical trial programs.

Active and upcoming clinical trials are shown below. These can be filtered by clinical phase, clinical trial status, and disease type. For more information about a specific trial click on the links within each box.